Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

OTTESON JASON G — PharmaFrontiers Corp. insider: 1 transactions · InsiderLens

Home / Insiders / OTTESON JASON G

OTTESON JASON G

Director at PharmaFrontiers Corp. · on record since Mar 5, 2004
CEO and CFO at PharmaFrontiers Corp. · on record since Mar 5, 2004
10% owner at PharmaFrontiers Corp. · on record since Mar 5, 2004

Insider trading activity of OTTESON JASON G

Transactions on record: 1; since Mar 5, 2004

Open-market buys: 1

Open-market sells: 0

Companies traded: 1; last filing Mar 5, 2004

Figures computed from official regulatory filings — methodology.

Companies where OTTESON JASON G has traded

PharmaFrontiers Corp.1 tx · Mar 5, 2004

Track record of OTTESON JASON G

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of OTTESON JASON G

Co-insiders of OTTESON JASON G

Adduci JeffreyPharmaFrontiers Corp.
Albert & Margaret Alkek FoundationPharmaFrontiers Corp.
Amello JasonPharmaFrontiers Corp.
Andrews William T.PharmaFrontiers Corp.
ASELAGE STEVEPharmaFrontiers Corp.
Bailey GregoryPharmaFrontiers Corp.
BARABE TIMOTHY CPharmaFrontiers Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Beeby ReshenthaPharmaFrontiers Corp.

Birner HubertPharmaFrontiers Corp.

BOVEROUX BROOKSPharmaFrontiers Corp.

BURRIS MICHELLEPharmaFrontiers Corp.

Davis Jefferson EPharmaFrontiers Corp.

DESLATTE DWAYNEPharmaFrontiers Corp.

DUNN JOHN MICHAELPharmaFrontiers Corp.

Fischer StefanPharmaFrontiers Corp.

Frison PaulPharmaFrontiers Corp.

FRITZSCHE R WAYNEPharmaFrontiers Corp.

Gow Robert HPharmaFrontiers Corp.

Hartung Hans-PeterPharmaFrontiers Corp.

Hayden TanyaPharmaFrontiers Corp.

Healey DonPharmaFrontiers Corp.

Hohlfeld LynnePharmaFrontiers Corp.

Hung DavidPharmaFrontiers Corp.

JARKESY GEORGEPharmaFrontiers Corp.

JORDEN DAVID EMERSONPharmaFrontiers Corp.

Joseph DonaldPharmaFrontiers Corp.

Jutt-Eghbali SalmaPharmaFrontiers Corp.

Kamin TonyPharmaFrontiers Corp.

Klopp John MichaelPharmaFrontiers Corp.

Lau Warren CPharmaFrontiers Corp.

Leatt GaryPharmaFrontiers Corp.

Litowitz Alec NPharmaFrontiers Corp.

Maderis Gail JPharmaFrontiers Corp.

Magnetar Capital Partners LPPharmaFrontiers Corp.

Magnetar Financial LLCPharmaFrontiers Corp.

Marengere LucPharmaFrontiers Corp.

MARXE AUSTIN W & GREENHOUSE DAVID MPharmaFrontiers Corp.

McWilliams DavidPharmaFrontiers Corp.

PALMIN HARRY SPharmaFrontiers Corp.

Paul Bernard HPharmaFrontiers Corp.

Quartel Adrian WPharmaFrontiers Corp.

Radhakrishnan KarthikPharmaFrontiers Corp.

Randall LorinPharmaFrontiers Corp.

Richman MichaelPharmaFrontiers Corp.

Rill Donna RPharmaFrontiers Corp.

Rodriguez BrianPharmaFrontiers Corp.

ROTH MICHAELPharmaFrontiers Corp.

Rouse WilliamPharmaFrontiers Corp.

Schelling ChrisPharmaFrontiers Corp.

SCHUHSLER HELMUTPharmaFrontiers Corp.

Company	Filed	Type	Qty	Price	Value · USD	Src
PharmaFrontiers Corp.	Mar 5, 2004	Buy	12,500,000	0.00 USD	—	SEC